Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events

SIMPLE SUMMARY: Although polyinosinic-polycytidylic acid-poly-l-lysine carboxymethylcellulose (poly-ICLC) is widely used as a standalone agent for treating human cancers, there are no reports on its use for treating canine cancers. We aimed to investigate the clinical efficacy, quality of life, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Voges, Alessandra Rinah Nogueira, Ubukata, Rodrigo, Yazbek, Karina Velloso Braga, Caballero, Otávia Luisa, Salazar, Andres Mario, Massoco, Cristina de Oliveira, Dagli, Maria Lucia Zaidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124725/
https://www.ncbi.nlm.nih.gov/pubmed/34066908
http://dx.doi.org/10.3390/cancers13092237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124725/
https://www.ncbi.nlm.nih.gov/pubmed/34066908
http://dx.doi.org/10.3390/cancers13092237

Ejemplares similares